21 – 30 of 33
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
A maximum likelihood estimator of a Markov model for disease activity in Crohn's disease and ulcerative colitis for annually aggregated partial observations.
(
- Contribution to journal › Article
- 2009
-
Mark
A Cost Effectiveness Analysis Of A General Vaccination Programme With The New 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein-D Conjugate Vaccine (Phid-Cv) In Sweden
(
- Contribution to journal › Published meeting abstract
-
Mark
Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohort.
(
- Contribution to journal › Article
- 2008
-
Mark
The Swedish cost burden of overweight and obesity - Evaluated with the PAR approach and a statistical modelling approach
(
- Contribution to journal › Article
-
Mark
The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: a Markov model.
(
- Contribution to journal › Article
- 2007
-
Mark
Retrospective incremental cost analysis of a hospital-based COPD Disease Management Programme in Sweden
(
- Contribution to journal › Article
-
Mark
Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades : A population-based study from Copenhagen, Denmark
(
- Contribution to journal › Article
- 2006
-
Mark
Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: a decision-analytic model.
(
- Contribution to journal › Article
- 2005
-
Mark
Obesity, survival, and hospital costs-findings from a screening project in sweden.
(
- Contribution to journal › Article
-
Mark
Epoetin alfa and darbepoetin alfa for the treatment of chemotherapy-related anemia in cancer patients in sweden: comparative analysis of drug utilization, costs, and hematologic response.
(
- Contribution to journal › Article